| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $127,184,267 | 35 | 100 |
| Rahmer Peter | See remarks | 0 | $0 | 7 | $1.18M | $-1.18M |
| Bergstrom Donald A | President, R&D | 0 | $0 | 8 | $2.18M | $-2.18M |
| Catinazzo Thomas | Chief Financial Officer | 0 | $0 | 14 | $3.37M | $-3.37M |
| Patel Sanjiv | President and CEO | 0 | $0 | 6 | $4.48M | $-4.48M |
| SVF Pauling (Cayman) Ltd | 10 percent owner | 0 | $0 | 1 | $116.4M | $-116.4M |
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced …
Over the last 12 months, insiders at Relay Therapeutics, Inc. have bought $0 and sold $127.18M worth of Relay Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Relay Therapeutics, Inc. have bought $0 and sold $29.66M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $200,000 was made by Adams Brian (General Counsel) on 2020‑07‑20.
| 2026-10-28 | Sale | Bergstrom Donald A | President, R&D | 2,252 0.001% | $18.62 | $41,932 | -9.12% | |
| 2026-10-28 | Sale | Rahmer Peter | See remarks | 753 0.0003% | $18.62 | $14,021 | -9.12% | |
| 2026-10-28 | Sale | Catinazzo Thomas | Chief Financial Officer | 1,469 0.0006% | $18.62 | $27,353 | -9.12% | |
| 2026-10-07 | Sale | Patel Sanjiv | President and CEO | 48,199 0.0222% | $18.10 | $872,402 | +0.17% | |
| 2026-10-06 | Sale | Catinazzo Thomas | Chief Financial Officer | 17,717 0.008% | $18.59 | $329,322 | -4.14% | |
| 2026-09-08 | Sale | Patel Sanjiv | President and CEO | 48,199 0.0235% | $18.94 | $912,889 | -4.00% | |
| 2026-09-08 | Sale | Bergstrom Donald A | President, R&D | 8,530 0.0042% | $18.97 | $161,814 | -4.00% | |
| 2026-09-08 | Sale | Catinazzo Thomas | Chief Financial Officer | 17,717 0.0087% | $18.94 | $335,560 | -4.00% | |
| 2026-08-26 | Sale | Rahmer Peter | See remarks | 4,508 0.0021% | $20.03 | $90,295 | -5.29% | |
| 2026-08-25 | Sale | SVF Pauling (Cayman) Ltd | 10 percent owner | 6M 2.5822% | $19.40 | $116.4M | -10.31% | |
| 2026-08-17 | Sale | Patel Sanjiv | President and CEO | 48,199 0.0234% | $20.33 | $979,886 | -10.45% | |
| 2026-08-14 | Sale | Catinazzo Thomas | Chief Financial Officer | 17,717 0.0087% | $19.74 | $349,734 | -6.42% | |
| 2026-07-28 | Sale | Bergstrom Donald A | President, R&D | 2,237 0.0013% | $18.61 | $41,631 | +3.01% | |
| 2026-07-28 | Sale | Rahmer Peter | See remarks | 748 0.0004% | $18.61 | $13,920 | +3.01% | |
| 2026-07-28 | Sale | Catinazzo Thomas | Chief Financial Officer | 1,459 0.0008% | $18.61 | $27,152 | +3.01% | |
| 2026-07-07 | Sale | Patel Sanjiv | President and CEO | 48,199 0.0273% | $19.58 | $943,736 | -4.36% | |
| 2026-07-06 | Sale | Bergstrom Donald A | President, R&D | 8,660 0.0049% | $18.71 | $162,029 | -0.05% | |
| 2026-07-06 | Sale | Catinazzo Thomas | Chief Financial Officer | 17,717 0.01% | $18.69 | $331,131 | -0.05% | |
| 2026-06-30 | Sale | Rahmer Peter | See remarks | 50,000 0.0291% | $19.09 | $954,500 | +0.91% | |
| 2026-06-22 | Sale | Bergstrom Donald A | President, R&D | 93,456 0.0523% | $16.94 | $1.58M | +9.03% |
| Patel Sanjiv | President and CEO | 471301 0.2151% | $8.22M | 1 | 26 | <0.0001% |
| Murcko Mark | 996952 0.4549% | $17.39M | 1 | 1 | <0.0001% | |
| Adams Brian | Chief Legal Officer | 371472 0.1695% | $6.48M | 1 | 39 | <0.0001% |
| INGRAM DOUGLAS S | director | 25000 0.0114% | $436,000.00 | 1 | 0 | <0.0001% |
| Rubin Jami | director | 25000 0.0114% | $436,000.00 | 1 | 0 | <0.0001% |
$11,583,737 | 45 | 49.75% | $4.66B | |
$104,428,685 | 44 | 22.55% | $3.78B | |
$1,275,975,557 | 32 | 19.44% | $3.54B | |
$151,136,640 | 31 | -1.41% | $3.95B | |
$5,066,938 | 27 | 26.38% | $3.7B |
| Increased Positions | 118 | +56.46% | 22M | +13.24% |
| Decreased Positions | 79 | -37.8% | 15M | -9.28% |
| New Positions | 49 | New | 12M | New |
| Sold Out Positions | 21 | Sold Out | 10M | Sold Out |
| Total Postitions | 248 | +18.66% | 172M | +3.96% |
| Sb Investment Advisers (Uk) Ltd | $228,263.00 | 16.13% | 27.9M | 0 | 0% | 2025-09-30 |
| Commodore Capital Lp | $139,060.00 | 9.83% | 17M | +4M | +27.34% | 2025-09-30 |
| Point72 Asset Management, L.P. | $120,849.00 | 8.54% | 14.77M | +1M | +9.88% | 2025-09-30 |
| Blackrock, Inc. | $112,552.00 | 7.95% | 13.76M | -195,104 | -1.4% | 2025-09-30 |
| Casdin Capital, Llc | $92,772.00 | 6.56% | 11.34M | -57,193 | -0.5% | 2025-09-30 |
| Vanguard Group Inc | $76,857.00 | 5.43% | 9.4M | +15,893 | +0.17% | 2025-09-30 |
| Bellevue Group Ag | $68,267.00 | 4.82% | 8.35M | +114,740 | +1.39% | 2025-09-30 |
| Tang Capital Management Llc | $65,997.00 | 4.66% | 8.07M | 0 | 0% | 2025-09-30 |
| State Street Corp | $41,440.00 | 2.93% | 5.07M | -136,801 | -2.63% | 2025-09-30 |
| Nextech Invest, Ltd. | $31,464.00 | 2.22% | 3.85M | 0 | 0% | 2025-09-30 |